| Dr Syed Ahmed Shah, MD | |
|
1007 Ml King Dr, Suite 1, Centralia, IL 62801-3003 | |
| (618) 533-9577 | |
| (618) 533-9588 |
| Full Name | Dr Syed Ahmed Shah |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 44 Years |
| Location | 1007 Ml King Dr, Centralia, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508867300 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 036097235 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Health - Good Samaritan Hospital | Mount vernon, IL | Hospital |
| Ssm Health St Mary's Hospital -centralia | Centralia, IL | Hospital |
| Franklin Hospital | Benton, IL | Hospital |
| Clay County Hospital | Flora, IL | Hospital |
| St Louis University Hospital | Saint louis, MO | Hospital |
| Entity Name | St Marys Hospital Centralia Illinois |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770687196 PECOS PAC ID: 6709788920 Enrollment ID: O20040127000118 |
News Archive
Genzyme, a Sanofi company, today announced that the company has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) and a marketing authorization application (MAA) to the European Medicines Agency (EMA) seeking approval of LEMTRADA (alemtuzumab) for treatment of relapsing multiple sclerosis (RMS).
Isotechnika Pharma Inc. today announced that it has developed a portfolio of non-immunosuppressive cyclosporine analogue molecules (NICAMs) with potent cyclophilin inhibition. Cyclophilin inhibition has garnered considerable attention as a novel therapy in the treatment of a wide range of diseases including hepatitis C, stroke, and chronic neurological disorders such as Parkinson's, Lou Gehrig's, and Alzheimer's.
Researchers from Qatar have demonstrated that antibody repertoires against endemic human coronaviruses are qualitatively different in children when compared to the general adult population, as well as healthy adult blood bank donors – and they may also provide cross-protection against epidemic/pandemic strains.
Scientists at Boston Biomedical Research Institute (BBRI) and the University of Pennsylvania have found that combining two chemicals, one of which is the green tea component EGCG, can prevent and destroy a variety of protein structures known as amyloids. Amyloids are the primary culprits in fatal brain disorders such as Alzheimer's, Huntington's, and Parkinson's diseases.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Syed Ahmed Shah, MD Po Box 431, Centralia, IL 62801-9107 Ph: (618) 533-9577 | Dr Syed Ahmed Shah, MD 1007 Ml King Dr, Suite 1, Centralia, IL 62801-3003 Ph: (618) 533-9577 |
News Archive
Genzyme, a Sanofi company, today announced that the company has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) and a marketing authorization application (MAA) to the European Medicines Agency (EMA) seeking approval of LEMTRADA (alemtuzumab) for treatment of relapsing multiple sclerosis (RMS).
Isotechnika Pharma Inc. today announced that it has developed a portfolio of non-immunosuppressive cyclosporine analogue molecules (NICAMs) with potent cyclophilin inhibition. Cyclophilin inhibition has garnered considerable attention as a novel therapy in the treatment of a wide range of diseases including hepatitis C, stroke, and chronic neurological disorders such as Parkinson's, Lou Gehrig's, and Alzheimer's.
Researchers from Qatar have demonstrated that antibody repertoires against endemic human coronaviruses are qualitatively different in children when compared to the general adult population, as well as healthy adult blood bank donors – and they may also provide cross-protection against epidemic/pandemic strains.
Scientists at Boston Biomedical Research Institute (BBRI) and the University of Pennsylvania have found that combining two chemicals, one of which is the green tea component EGCG, can prevent and destroy a variety of protein structures known as amyloids. Amyloids are the primary culprits in fatal brain disorders such as Alzheimer's, Huntington's, and Parkinson's diseases.
› Verified 9 days ago
Alexander Diaz Seger, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 400 N Pleasant Ave, Centralia, IL 62801 Phone: 618-436-8000 | |
Dr. Robert Mitchell Norman, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 444 N Pleasant Ave, Centralia, IL 62801 Phone: 618-436-5665 | |
Dr. Sajjan K Nemani, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1054 Martin Luther King, Suite 124, Centralia, IL 62801 Phone: 618-533-8700 Fax: 618-533-8701 | |
Dr. Melissa Aberg West, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 904 E. Martin Luther King Drive, Centralia, IL 62801 Phone: 618-533-1391 Fax: 618-533-0012 |